abc
QUICK LINKS:

FDA Clears Johnson & Johnson Hepatitis C Drug

Created: 11/22/2013 7:50 PM KSTP.com
By: Cassie Hart

Federal regulators have approved a new drug from Johnson & Johnson for use in treating chronic hepatitis C infections.
    
The U.S. Food and Drug Administration said Friday it approved the drug, a protease inhibitor that blocks a protein needed by the virus to replicate.
    
The Johnson & Johnson drug is designed to eliminate hepatitis C, the most common form of the liver-destroying virus. It is a daily pill taken in combination with the long-established drug cocktail used to treat the most common form of the virus.
    
The FDA's decision comes less than a month after an FDA advisory panel voted unanimously in favor of approving the treatment.
    
More than 3 million people in the U.S. have hepatitis C, a blood-borne disease that is blamed for 15,000 deaths a year.

(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
 

Image: MGN Online

Minneapolis/St. Paul

Few Clouds
83°
82° | 63°
  • Feels like: 83° F
  • Wind: NNW 8mph
  • Humidity: 32%
  • Fri Partly cloudy, chance of a thunderstorm
    83° | 65°
  • Sat A few clouds
    83° | 65°
  • Sun A few morning showers
    85° | 67°
  • Mon Times of sun and clouds
    82° | 65°

Video

KSTP NEWS